About CONMED
CONMED is a company based in Utica (United States) founded in 1987 by Eugene Corasanti. The company has 3,900 employees as of December 31, 2024. CONMED has completed 7 acquisitions, including Buffalo Filter, In2Bones and In2Bones USA. CONMED offers products and services including AirSeal, BioBrace, and Argo Knotless. CONMED operates in a competitive market with competitors including GE Healthcare, Medtronic, Boston Scientific, Johnson & Johnson and Commure, among others.
- Headquarter Utica, United States
- Employees 3900 as on 31 Dec, 2024
- Founders Eugene Corasanti
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Conmed Corporation
-
Annual Revenue
$1.3 B (USD)4.98as on Dec 31, 2024
-
Net Profit
$132.42 M (USD)105.44as on Dec 31, 2024
-
EBITDA
$215.53 M (USD)18.3as on Dec 31, 2024
-
Latest Funding Round
$345 M (USD), Post-IPO
Mar 03, 2019
-
Investors
Barclays
& 1 more
-
Employee Count
3900
as on Dec 31, 2024
-
Investments & Acquisitions
Buffalo Filter
& 6 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CONMED
CONMED is a publicly listed company on the NYSE with ticker symbol CNMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of CONMED
CONMED offers a comprehensive portfolio of products and services, including AirSeal, BioBrace, and Argo Knotless.
Maintains stable pressure for laparoscopic and robotic surgeries
Reinforces tendons and ligaments in orthopedic procedures
Adjusts tension for secure surgical fixation
People of CONMED
Unlock access to complete
Unlock access to complete
Funding Insights of CONMED
Investors in CONMED
CONMED has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Barclays and J P Morgan Wealth Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides banking, credit cards, investments, loans, and auto financing services.
|
Locked | Locked | Locked | |
|
Diversified financial services are provided across global markets.
|
Locked | Locked | Locked |
Investor details for CONMED
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CONMED
CONMED has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Buffalo Filter, In2Bones and In2Bones USA.
Investment portfolio details for CONMED
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Plating and fixation systems are developed for orthopedic applications.
|
Locked | Locked | 2014 | Locked | |
|
Provider of single use surgical instruments and orthopedic implants for use in lower extremity surgeries.
|
Locked | Locked | 2011 | Locked | |
|
Products for minimally invasive surgery are developed and supplied.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for CONMED
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CONMED
Detailed financials for CONMED
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Conmed Comparisons
Peer comparison for CONMED
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CONMED
CONMED operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GE Healthcare, Medtronic, Boston Scientific, Johnson & Johnson and Commure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Materials management solutions are provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Medical equipment for treating over 30 chronic diseases is developed.
|
|
| Locked | Locked | Locked |
Wide range of medical devices
|
|
| Locked | Locked | Locked |
Healthcare solutions are provided by Johnson & Johnson globally.
|
|
| Locked | Locked | Locked |
Complex healthcare challenges are addressed through technology solutions by Commure.
|
Detailed competitors of CONMED
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Conmed
Complete news archive for CONMED
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CONMED
CONMED was founded in 1987 and raised its 1st funding round 17 years after it was founded.
CONMED is headquartered in Utica, United States. It is registered at Utica, New York, United States.
Curt Hartman is the current CEO of CONMED.
As of Dec 31, 2024, the latest employee count at CONMED is 3,900.
Annual revenue of CONMED is $1.3B as on Dec 31, 2024.
CONMED was established in 1987 in Utica, United States, as a medical device company. Emphasis is placed on research and development for manufacturing surgical instruments and equipment used in minimally invasive procedures. Products are applied across specialties including general surgery, urology, gynecology, colorectal, and gastroenterology. Operations center on supporting surgeons and physicians with tools for various therapeutic needs.
CONMED's top competitors include GE Healthcare, Medtronic and Boston Scientific.
CONMED offers AirSeal, BioBrace, and Argo Knotless.
Yes, CONMED is publicly traded on NYSE under the ticker symbol CNMD.
CONMED has made 7 acquisitions, including Buffalo Filter, In2Bones, and In2Bones USA.
CONMED has 2 investors. Key investors include Barclays, and J P Morgan Wealth Management.
The ticker symbol of CONMED is CNMD on NYSE.